Rhythm Pharmaceuticals, Inc.
RYTM
$115.48
-$0.54-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.40% | -17.12% | 10.21% | -13.45% | 5.79% |
| Total Depreciation and Amortization | -0.40% | -7.35% | -10.53% | -19.79% | -1.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.65% | 25.20% | -1.47% | 24.20% | 10.45% |
| Change in Net Operating Assets | 162.62% | -2,361.79% | -122.24% | -31.34% | 157.21% |
| Cash from Operations | 79.29% | -74.03% | 4.63% | -14.19% | 42.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -75.44% | 82.27% | 112.71% | -555.90% | 117.78% |
| Cash from Investing | -75.44% | 88.00% | 112.32% | -555.90% | 117.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -4.72% | 199.59% | -98.74% | 5,559.92% | -90.72% |
| Repurchase of Common Stock | 85.14% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -61.08% | 20.59% | 3.05% | -28.58% | 6.13% |
| Cash from Financing | 78.43% | -83.18% | -101.56% | 21,393.70% | -102.74% |
| Foreign Exchange rate Adjustments | -148.44% | 600.00% | -78.95% | 208.96% | -13,850.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.05% | 281.63% | 102.49% | -382.07% | 74.28% |